Stock listing

KYTX Stock Price, News, Filings & Events — Kyverna Therapeutics, Inc.

Selected listing: KYTX · NASDAQ · USD · US

This page tracks Kyverna Therapeutics, Inc.'s KYTX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KYTX:NASDAQ. KYTX:NASDAQ is the stock-level entry point for investors researching Kyverna Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Kyverna Therapeutics, Inc. (ticker: KYTX) is a public company based in the United States, focused on developing innovative therapies. With a market capitalization of approximately $450.5 million, Kyverna is positioned within the biotechnology sector. The company aims to advance its research and development efforts to address unmet medical needs.

KYTX:NASDAQUSDUSUpdated September 11, 2026
Kyverna Therapeutics, Inc. logo
Ticker
KYTX:NASDAQ
Asset type
Stock
Market cap
$449.0M
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

Kyverna Therapeutics, Inc. KYTX:NASDAQ stock context

This page tracks Kyverna Therapeutics, Inc.'s KYTX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KYTX:NASDAQ. KYTX:NASDAQ is the stock-level entry point for investors researching Kyverna Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Kyverna Therapeutics, Inc. (ticker: KYTX) is a public company based in the United States, focused on developing innovative therapies. With a market capitalization of approximately $450.5 million, Kyverna is positioned within the biotechnology sector. The company aims to advance its research and development efforts to address unmet medical needs.

Latest news from Kyverna Therapeutics, Inc.

All Kyverna Therapeutics, Inc. news →

Research Kyverna Therapeutics, Inc.

Alternate listings